Genetic evidence for involvement of multiple effector systems in α(2A)- adrenergic receptor inhibition of stimulus-secretion coupling

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 96-103

  Lakhlani, Parul P ^a   Lovinger, David M ^a   Limbird, Lee E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALPHA 2A ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CYCLIC AMP; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; CORTICOTROPIN RELEASE; HORMONAL REGULATION; HYPOPHYSIS CELL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REGULATORY MECHANISM; STIMULUS SECRETION COUPLING;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; ASPARAGINE; ASPARTIC ACID; BARIUM; CALCIUM CHANNELS; CELL LINE; GTP-BINDING PROTEINS; ISOPROTERENOL; MUTAGENESIS, SITE-DIRECTED; PATCH-CLAMP TECHNIQUES; PITUITARY GLAND, ANTERIOR; POINT MUTATION; POTASSIUM CHANNELS; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; RECOMBINANT PROTEINS; SOMATOSTATIN;

EID: 0029895790     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 2-adrenoceptor subtypes. Annu. Rev. Pharmacol Toxicol 33:243-79 (1993).
2. Dorflinger, L. J., and A. Schonbrunn. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells. Endocrinology 113:1551-1558 (1983).
3. Dolphin, A. C., and S. A. Prestwich. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release. Nature (Lond.) 316:148-150 (1985).
4. 2-adrenoceptor-mediated inhibition of noradrenaline release in the rat brain: role of hyperpolarization? Eur. J. Pharmacol. 105:129-135 (1984).
5. 2 adrenergic receptors, in The Alpha-2 Adrenergic Receptors (L. E. Limbird, ed). Humana Press, Clifton, New Jersey, 323-326 (1988).
6. Limbird, L. E. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J. 2:2686-2695 (1988).
7. 2-adrenergic inhibition of insulin release: studies with epinephrine and forskolin. J. Biol. Chem, 259:4111-4115 (1984).
8. 1-receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:477-483.
9. Surprenant, A., K.-Z, Shen, R. A. North, and H. Tatsumi. Inhibition of calcium currents by noradrenaline, somatostatin and opioids in guinea-pig submucosal neurons. J. Physiol. 431:585-608 (1990).
10. Williams, J. T., and R. A. North. Catecholamine inhibition of calcium action potentials in rat locue coeruleus neurones. Neuroscience 14:103-109 (1985).
11. Cook, D. L., and E. Perara. Islet electrical pacemaker response to alpha-adrenergic stimulation. Diabetes 31:985-990 (1982).
12. 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science (Washington D. C.) 215:1394-1396 (1982).
13. Morita, K., and R. A. North. Clonidine activates membrane potassium conductance in myenteric neurons. Br. J. Pharmacol. 74:419-428 (1981).
14. 2-adrenoceptor-coupled regulation of electrically evoked noradrenaline release in hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 347: 14-20 (1993).
15. Koch, B. D., J. B. Blalock, and A. Schonbrunn. Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin. J. Biol. Chem. 263:216-225 (1988).
16. 2-adrenergic receptor-G protein interactions. J. Biol. Chem. 269:29557-29564 (1994).
17. 2-adrenergic receptors by sodium. J. Biol. Chem. 265:21590-21595 (1990).
18. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science (Washington D. C.) 257:977-980 (1992).
19. Nicholson, W. E., D. R. Davis, B. J. Sherrell, and D. N. North. Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin. Chem. 30:259-265 (1984).
20. Mahy, N., M. Woolkalis, K Thermos, K. Carlson, D. Manning, and T. Reisine. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells. J. Pharmacol. Exp. Ther. 246:779-785 (1988).
21. Richardson, U. I., and A. Schonbrunn. Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture. Endocrinology 108: 281-290 (1981).
22. Dousmanis, A. G., and P. S. Pennefather. Inwardly rectifying potassium conductances in AtT-20 clonal pituitary cells. Pfluegers Arch. 422:98-104 (1992).
23. Heisler, S., T. D. Reisine, Y. H. V. Hook, and J. Axelrod. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells. Proc. Natl. Acad. Sci. USA 79:6502-6506 (1982).
24. Luini, A., D. Lewis, S. Guild, G. Schofield, and F. Weight. Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line. J. Neurosci. 6:3128-3132 (1986).
25. Surprenant, A. Correlation between electrical activity and ACTH/β-endorphin secretion in mouse pituitary tumor cells. J. Cell. Biol. 95:559-566 (1982).
26. Litvin, Y., R. PasMantier, N. Fleischer, and J. Erlichman. Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells: preferential activation of protein kinase 1 by corticotrophin releasing factor, isoproterenol, and forskolin. J. Biol. Chem. 259:10296-10302 (1984).
27. Schecterson, L. C., and G. S. McKnight. Role of cyclic adenosine 3′,5′-monophosphate-dependent protein kinase in hormone-stimulated β-endorphin secretion in AtT20 cells. Mol. Endocrinol. 6:170-178 (1991).
28. Miller, J. P. Cyclic nucleotide analogs, in Cyclic-3′,5′-Nucleotides: Mechanism of Action. (J. Schulz, ed.). Wiley and Sons, New York, 77-104 (1977).
29. Beebe, S. J., P. F. Blackmore, T. D. Chrisman, and J. D. Corbin. Use of synergistic pairs of site-selective cAMP analogs in intact cells. Methods Enzymol. 159:118-139 (1988).
30. 1 to decreases in intracellular free calcium. J. Biol. Chem. 260:13138-13145 (1985).
31. Reisine, T. D. Somatostatin inhibition of cyclic AMP accumulation and adrenocorticotropin release from mouse anterior pituitary tumor cells: mode of action and self-regulation. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 19:169-177 (1985).
32. 2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. Mol. Pharmacol. 39:239-245 (1991).
33. Lipscombe, D., S. Kongsamut, and R. W. Tsien. Alpha-adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium channel gating. Nature (Lond.) 340:639-642 (1989).
34. Matsuuchi, L., and R. B. Kelly. Constitutive and basal secretion from the endocrine cell line, AtT-20. J. Cell Biol. 112:843-852 (1991).
35. Adler, M., B. S. Wong, S. L. Sabol, N. Busis, M. B. Jackson, and F. F. Weight. Action potentials and membrane ion channels in clonal anterior pituitary cells. Proc. Natl. Acad. Sci. USA 80:2086-2090 (1983).
36. Pennfather, P. S., S. Heisler, and J. F. MacDonald. A potassium conductance contributes to the action of somatostatin-14 to suppress ACTH secretion. Brain Res. 444:346-350 (1988).
37. α subunits. EMBO J. 14:3635-3644 (1995).
38. + currents in guinea pig chromaffin cella. J. Gen. Physiol. 106:249-266 (1995).
39. + channel function in rat atrial cells by phosphorylation. J. Physiol. 437:133-155 (1991).
40. A receptor-mediated chloride current in cultured rat hippocampal neurons via an extracellular site. J. Pharmocol. Exp. Ther. 255:90-94 (1990).